evt | Article | June 2007
Setting the Stage for Future Lower-Extremity Device Trials
Krishna Rocha-Singh, MD, of VIVA Physicians, Inc., discusses their effort to determine nitinol stenting performance goals, collaboration with the FDA and industry, and how clinicians can apply these standards to their practices.
By Krishna Rocha-Singh, MD
Sponsored by Medtronic
evt | Article | November 2016
Sponsored by ROX Medical
evt | Article | September 2018
Considering a New Approach to Treatment of Uncontrolled Hypertension With the ROX Coupler Device
A discussion with Dr. Krishna Rocha-Singh and Prof. Dr. Felix Mahfoud on what makes the ROX Coupler device different from other hypertension interventions, how to implant the device, clinical study results, and anticipated results from ongoing studies.
With Krishna Rocha-Singh, MD, and Felix Mahfoud, MD
Sponsored by Medtronic, Inc.
evt | Article | Global Spring 2014 Supplement
Sponsored by Spectranetics
evt | Article | Europe May 2015 Supplement
Sponsored by Boston Scientific Corporation
evt | Article | June 2015
evt | Article | September 2017
Sponsored by Medtronic plc
evt | Article | February 2015 Supplement
DCB Use in the Real World
A panel of experts discusses recommendations for optimizing outcomes when treating complex SFA and popliteal lesions with drug-coated balloon technology.
With Peter A. Schneider, MD; Prakash Krishnan, MD; Jos C. van den Berg, MD, PhD; Gunnar Tepe, MD; Lawrence A. Garcia, MD; and Krishna Rocha-Singh, MD
evt | Article | October 2016
Ask the Experts: What SFA Trials Would You Most Like to See?
Experts discuss key questions to answer, potential trial designs, and the likelihood that the trials will be undertaken.
With Peter A. Schneider, MD; Thomas Zeller, MD; Osamu Iida, MD; Marianne Brodmann, MD; Krishna Rocha-Singh, MD; and Christopher Metzger, MD
evt | News | October 9, 2013
evt | News | December 24, 2012
ZEN Trial Shows DES to Be Safe and Feasible for ED, But Challenges Remain
December 25, 2012—Jason H. Rogers, MD, and coprincipal investigators Krishna Rocha-Singh, MD, and Irwin Goldstein, MD, published 6-month follow-up results from the first-in-man ZEN trial in the Journal of the American College of Cardiology (2012;60:2618–2627). The ZEN trial findings demonstrate that the use of drug-eluting stents to treat erectile dysfunction (ED) is both feasible and safe. However, Dr. Rogers explained that challenges remain and further study is needed before this treatment is more widely utilized.
evt | News | October 21, 2009
Renal Denervation Lowers Blood Pressure in Hypertension Patients in Ardian US Pilot Study
October 22, 2009—Study results showing that catheter-based renal denervation yields significant and sustained reductions in blood pressure in patients with multidrug-resistant hypertension were presented at the Vascular Interventional Advances meeting in Las Vegas, Nevada, by Krishna Rocha-Singh, MD, FACC.
evt | News | May 27, 2020
VIVA's Paclitaxel Analysis Finds Increased Mortality Risk, But No Dose Association; Lead Author Encourages Close Read
May 27, 2020—Earlier this month, VIVA Physicians announced the publication of an analysis of mortality and paclitaxel-coated devices by Krishna Rocha-Singh, MD, et al, which is available online ahead of print in Circulation.